Plain-English translation of NCT05500391 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether patients who have been treated for certain early-stage cancers can be safely monitored for cancer return through remote video or phone appointments with a nurse, rather than traveling to the hospital for in-person visits with a doctor. The study will follow patients for up to 5 years to see if both approaches work equally well, and whether remote monitoring is easier for patients to stick with.
After cancer treatment, patients need regular check-ups to catch any signs of the cancer coming back early. This study wants to know if remote monitoring by a nurse can work just as well as traditional hospital visits, while potentially being more convenient and reducing the burden of travel on patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either receive remote monitoring with a nurse (using phone or video calls) or continue with regular in-person visits to the hospital with a doctor. Both groups will follow the same surveillance plan recommended for your type of cancer. The study will track how well you stick with your appointments over 2 years, and will continue following you for up to 5 years total to see if there are any differences in outcomes, costs, or how satisfied you feel with your care.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
France